Dimensional Fund Advisors LP Increases Stake in Doximity, Inc. (NASDAQ:DOCS)

Dimensional Fund Advisors LP lifted its position in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 4.2% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,576,455 shares of the company's stock after buying an additional 63,815 shares during the period. Dimensional Fund Advisors LP owned approximately 0.84% of Doximity worth $84,167,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of DOCS. Morse Asset Management Inc acquired a new position in Doximity during the 3rd quarter valued at about $46,000. Barclays PLC grew its position in Doximity by 60.5% during the 3rd quarter. Barclays PLC now owns 53,401 shares of the company's stock worth $2,327,000 after purchasing an additional 20,125 shares during the period. Wilmington Savings Fund Society FSB acquired a new stake in Doximity during the third quarter worth about $24,691,000. Franklin Resources Inc. grew its stake in shares of Doximity by 564.1% during the 3rd quarter. Franklin Resources Inc. now owns 83,098 shares of the company's stock worth $3,487,000 after purchasing an additional 70,585 shares during the period. Finally, American Trust purchased a new position in Doximity in the third quarter valued at $247,000. Institutional investors own 87.19% of the company's stock.

Doximity Stock Up 2.0 %

NASDAQ DOCS traded up $1.19 on Friday, reaching $59.26. The stock had a trading volume of 1,434,828 shares, compared to its average volume of 1,999,254. The firm has a market capitalization of $11.06 billion, a price-to-earnings ratio of 59.26, a P/E/G ratio of 4.10 and a beta of 1.41. Doximity, Inc. has a 12-month low of $22.96 and a 12-month high of $85.21. The stock has a fifty day moving average price of $59.10 and a two-hundred day moving average price of $56.60.

Insider Buying and Selling

In related news, Director Timothy S. Cabral sold 20,000 shares of the company's stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the sale, the director now directly owns 6,360 shares in the company, valued at approximately $366,463.20. This represents a 75.87 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Anna Bryson sold 45,000 shares of the firm's stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $57.23, for a total value of $2,575,350.00. Following the completion of the sale, the chief financial officer now owns 357,165 shares in the company, valued at approximately $20,440,552.95. This represents a 11.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 67,000 shares of company stock valued at $3,841,610 in the last ninety days. Company insiders own 37.40% of the company's stock.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on the stock. Bank of America lifted their price target on shares of Doximity from $54.00 to $57.00 and gave the company a "neutral" rating in a research note on Monday, January 6th. Leerink Partnrs upgraded shares of Doximity from a "hold" rating to a "strong-buy" rating in a research report on Friday, February 7th. Needham & Company LLC lifted their price objective on Doximity from $65.00 to $82.00 and gave the stock a "buy" rating in a report on Friday, February 7th. Raymond James reissued an "outperform" rating and set a $83.00 target price (up previously from $65.00) on shares of Doximity in a report on Friday, February 7th. Finally, Morgan Stanley lowered their price target on Doximity from $71.00 to $60.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 24th. Eleven research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $65.39.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.